Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis (Q90181901)
Jump to navigation
Jump to search
scientific article published on 01 November 2019
Language | Label | Description | Also known as |
---|---|---|---|
English | Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis |
scientific article published on 01 November 2019 |
Statements
Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis (English)
Mounica Vallurupalli